Weight Loss Clinical Trials in Texas

23 recruiting studies across 6 cities

Browse by City

Arlington

All Trials in Texas

Phase

Trial	Phase	Sponsor	Dist.
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities	Phase 2	Verdiva Bio Dev Limited	<1 mi
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes	Phase 1	Eli Lilly and Company	<1 mi
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation	N/A	VA Office of Research and Development	<1 mi
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults	Phase 2	The University of Texas Health Science Center at San Antonio	<1 mi
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes	Phase 4	Marzieh Salehi	<1 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	<1 mi
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity	N/A	The Methodist Hospital Research Institute	<1 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	<1 mi
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study	Early 1	M.D. Anderson Cancer Center	<1 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	<1 mi
Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino	N/A	Baylor Research Institute	<1 mi
The Effect of Adiposity on Muscle and Microvascular Function in HFpEF	—	University of Texas Southwestern Medical Center	<1 mi
Tailored Exercise Training Study Among Adults With HFpEF	Phase 2/3	University of Texas Southwestern Medical Center	<1 mi
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)	N/A	Baylor Research Institute	<1 mi
Tirzepatide Weight Loss for MRD+ Early Breast Cancer	Phase 2	Baylor Research Institute	<1 mi
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance	Phase 4	AbbVie	7 mi
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss	—	Boston Scientific Corporation	7 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy	Phase 2	Endevica Bio	23 mi
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia	Phase 1	AVEO Pharmaceuticals, Inc.	23 mi
The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery	—	The University of Texas Medical Branch, Galveston	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.